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i. Abstract  
Title: Investment in Hybrid Organizations in Healthcare 
Author: Gonçalo Espanha Torrado da Silva  
Innovation in health is a pressing need throughout the world, whether to solve public health 
challenges, to assure the sustainability of national health services or even improve the population’s 
quality of life. 
Investors have been showing a growing interest in projects with social character; furthermore, there 
has been a growing emergence of hybrid organizations that combine social and financial goals. Due 
to the social impact closely associated with innovation in health, many projects in this industry are 
considered hybrid organizations. Therefore, there is a window of opportunity for investment that 
organizations in the healthcare industry should use in their advantage. It is crucial, however, that these 
organizations learn how to effectively capture investment. 
Through an exploratory study, this dissertation aims to understand what are the main factors that 
hybrid organizations in the healthcare industry must focus in order to capture investment. Using a 
qualitative approach, 15 specialists in this industry were interviewed: founders/ CEOs of the 
companies, investors and accelerators.  
By analyzing the interviews, and considering the specificities of the health industry, six factors were 
identified: Innovation, Market Drive, Team, Stakeholder Validation, and Intellectual Property. Still 
companies must not focus on one factor only, since, excelling at just one of them may be insufficient 
to capture investment. Entrepreneurs must deliver a compelling combination of these six factors in 
order maximize their chances of attracting the necessary capital. 







Seja para resolver problemas de saúde pública, de sustentabilidade dos serviços nacionais de saúde 
ou para melhorar a qualidade de vida das populações, a inovação em saúde é uma necessidade 
premente por todo o mundo.  
Atualmente tem-se registado um crescente interesse dos investidores em projetos com carácter social, 
verificando-se o surgimento de organizações híbridas que combinam objetivos sociais e financeiros. 
O impacto social inerente à inovação na área de saúde leva a que seja possível considerar muitas das 
empresas neste mercado como organizações híbridas. Existe então uma janela de oportunidade que 
estas organizações podem aproveitar, no entanto é essencial que estas tenham consciência de como 
conseguem satisfazer as suas necessidades de financiamento. 
Assim sendo, esta dissertação tem como objetivo, através de um estudo exploratório, perceber quais 
os fatores nos quais as organizações híbridas se devem focar para captarem o financiamento 
necessário. Para este fim foi utilizada uma abordagem qualitativa, tendo sido entrevistados 15 
especialistas na indústria: fundadores/ diretores de empresas, investidores e aceleradores.  
Através das entrevistas foi possível identificar seis fatores que, tendo em conta as especificidades da 
indústria da saúde, aumentam a atratividade dos projetos aos olhos de investidores: Inovação, Foco 
no Mercado, Equipa, Validação de Stakeholders, Propriedade Intelectual, Impacto Social. No entanto 
um empreendedor não se deve focar em primar apenas num fator, pois isso poderá não ser suficiente 
para captar o financiamento necessário. Os projetos devem oferecer uma combinação dos seis fatores 
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1.1. Problem Definition and Relevance 
In Europe, health and social care systems are facing increasing demands at a time when resources are 
increasingly constrained (Davies & Boelman, 2016). In the United States, the Affordable Care Act 
and the American Health Care Act are currently on the brink of the news due to the increasing 
concerns of the American people about their national health service. In Africa, public health 
challenges such as malaria, tuberculosis or HIV are still responsible for huge numbers of deaths and 
reduced living standards of the population (Friends of the Global Fight, 2017). This way, all around 
the globe, we see that there is a strong case for investment in social innovations that tackle such 
challenges. 
Focusing on the health sector and bearing in mind that fundraising, when dependent of donations, is 
often challenging due to many different reasons – whether it is the growing competition for the same 
resources, donor fatigue and/ or limited funding as government and philanthropic contributions 
stagnate or decline (Durakovic et al., 2017) –, it is crucial for projects in this industry to understand 
all the financing options on their disposal. At the same time, impact investing is experiencing rapid 
growth in the past years – in 2011 alone, roughly 60 new impact investment funds were established, 
compared with 44 in 2010 and 20 in 2009 (Höchstädter & Scheck, 2015) – with investors looking for 
new projects to invest (Durakovic et al., 2017). 
These two simultaneous phenomena – health issues as one of the major concerns of this era and the 
rapid growth of impact investing – represent an opportunity for all actors in the sector. Whether they 
are investors, who may find new profitable projects; health industry enterprises, who are able to attract 
new forms of investment that allow them to scale and reach new markets; or the users, that benefit 
from better and efficient products and treatments that may, ultimately, save their lives.  
In the healthcare industry we find a match in the definition of new ventures and hybrid organizations. 
Hybrid organizations are enterprises steered by different institutional logics (Pache & Santos, 2013). 
This way, and due to the impact inherently generated by the industry’s start-ups and the innovation 
they produce, it is reasonable to consider that most of the new ventures in the industry fit the 




Innovation in health is not only an outcome of development but also a prerequisite for it. 
Consequently, the investment on innovation yields one of the highest rates of return that a country 
can achieve either by improving quality of products and services or by constraining costs (Salge, 
2011). Healthcare innovation is, this way, so intricately associated with social responsibility, as 
imposed by bioethics entities, such as the International Bioethics Committees, that one start-up in the 
field will naturally tend to solve social problems whilst seeking financial return (UNESCO, 2010). 
Recognizing what are the main factors that drive investments in the health industry is crucial for the 
future behaviour of organizations in the market, and may help guide the behaviour of, not only the 
enterprises, but also the investors. Therefore this study will focus on what are the main factors that 
allow ventures in the health industry to become attractive opportunities for investors, being this way 
able of delivering disruptive innovation in the sector. 
1.2. Objective and Research Questions 
Historically, most healthcare related start-ups did not explore the financing option from private for-
profit sources, and instead turned to philanthropies and donations (Grazier & Metzler, 2006). 
However, this channel ability to meet the investment demand decreased with more competition for 
donations and new ventures had to approach the financing market differently. Therefore, nowadays, 
one of the major challenges start-ups in health face is exactly how to finance their operations, and a 
poor approach to this subject may lead to discouragement, ineffectiveness and ultimately hindering 
the growing prospects of the venture (Grazier & Metzler, 2006). 
Being that one of the major problems for the healthcare ventures to grow and for innovation to 
prosper, organizations must be clear providing the incentives that encourage investment on their 
enterprise (Law, 2000). Also, given the recent unstable financial markets and increased competition 
for private donations, new healthcare project often face unrealistic and unfavourable requirements for 
investment returns and time-to-market (Grazier & Metzler, 2006).  
Thus, we propose to clarify this subjects presenting which are the main factors that hybrid 
organizations must focus in order to attract investment. We will present it after observing the 
healthcare investment environment and its main obstacles, particularly in the Portuguese market.  
Therefore, the following research question is addressed:   
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How do hybrid organizations on healthcare attract investment? 
The answer will be provided, using a qualitative approach, by experts in the field, interviewing 
founders and/ or managers of hybrid organizations, impact investors with past investments in the 
sector and accelerators specialized in the industry. Focusing on the experience of these firms and 
projects, the aim is to add valuable insights related to the investment in hybrid organizations, creating 
understanding that can be verified in future researches (Gebhardt et al , 2006). 
1.3. Dissertation Structure 
This dissertation is divided in 7 chapters that are intended to provide the factors described above. The 
chapters are: Introduction; Literature Review; Context; Research Methodology; Data Analysis; 
Findings; Conclusion, Contributions, Limitations and Future Research.  
The first chapter, in which this topic Dissertation Structure is inserted, discusses the relevance of the 
presented subject, the objective and research question. This chapter provides as well a brief 
description of what will be the methodology used to answer such question. The second chapter 
provides a summary of what has already been study in the area and provides descriptions of crucial 
concepts that will be essential to address the research question. The third chapter introduces the 
Portuguese health care market and its recent developments. In the fourth chapter and fifth the adopted 
methodology and data analysis, respectively, are described, in line with the objectives and 
particularities of the dissertation. The sixth chapter reveals the obtained findings and summarizes 
them dividing it in distinct categories. Lastly, the seventh chapter has the main conclusion of the study 
and addresses the academic and practical contributions and limitations, closing with the proposal of 




2. Literature Review 
2.1. Hybrid Organizations 
During most of the past century, the private, public and non-profit sectors were clearly separate 
identities in which distinctive standard types of organizations, such as commercial businesses, public 
organizations and private charities, respectively, fell categorically (Battilana & Lee, 2014). 
Nonetheless, researchers assumed that these organizational forms were more rigid than they turned 
out to be (Markman et al., 2016) and, over the last three decades, the borders that separated these 
forms and their sectors have progressively dissipated (Battilana & Lee, 2014). The increase in the 
number of organizations that operate at the intersection between boundaries has been notable all over 
the world – in the U.S, for example, as Haight et al.( 2015, p. 5) explains:  
“With the market for socially and environmentally conscious products and services growing to 
$290 billion and the market for socially responsible investments growing to $3 trillion in assets 
in the U.S. alone (or 12% of professionally managed funds), there has naturally been a 
complementary growth in the popularity of organizations that seek to meet this market 
opportunity that we call “hybrid organizations”.” 
Such enterprises, named “hybrid organizations”, congregate different institutional logics (Battilana 
& Dorado, 2010). As Battilana and Lee (2014, p.400) state:  
“The concept of “hybridity”, in the abstract, refers to the state of being composed through the 
mixture of disparate parts. Specifically, hybridity describes direct constitution from existing 
elements. Hybrids are not objects composed entirely new, but are rather inter alia objects, 
composed through the recombination of existing elements.” 
Organizationally speaking, hybridization refers to combining parts of different institutions, fusing 
elements, stakeholders, value systems and operational logics, missions and agendas that in the past 
were considered to be restricted to one specific sector or organizational form (Markman et al., 2016). 
These organizations may congregate, for example, market and academic rationales, with the intention 
of advancing the medical discovery in biotechnology firms.  They can combine logics of government, 
commercial firms, and non-profit associations in public-private hybrid organizations to tackle the 
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challenge of climate change. Or even, logics of commercial and non-profit enterprises united to tackle 
the underdevelopment issues through microfinance organization (Jay, 2013). 
As organizations face the growing existence of multiple institutional spheres, known as institutional 
pluralism, hybrids are increasingly sought as a solution to tackle different institutional logics. Hybrid 
organizations, as members of more than one institutional sphere, are able to effectively respond to 
the particularities of pluralistic environments, incorporating elements of various logics and behaving 
appropriately before a wider set of institutional referents (Pache & Santos, 2013). 
One studied example of a hybrid organization is the Aravind Eye Hospital, a cataract-surgery 
organization based in Madurai, India. Aravind approaches a major cause of concern in the Indian 
healthcare scenario – unnecessary blindness – embracing social responsibilities, through a tier pricing 
method: wealthier patients pay close to market rates, knowingly subsidizing cataract-surgeries for 
poorer patients who get treated for free or minimal price. Through this model, Aravind is 
simultaneously market and mission oriented thus is able to reach its social goal whilst being 
financially sustainable. This is a model that literature on Corporate Social Responsibility and non-
profit management fails to explain since enterprises such as this one, which combines both business 
and charity, are still emerging (Battilana & Lee, 2014). 
It is clear, by now, that hybrid organizations are in constant conflict. They are stuck between 
contradictory claims due to the various logics that they gather. Thus, some questions are constantly 
raised, as Pache and Santos (2013, p. 972) state: 
“Should they incorporate as for-profit or as not-for-profit entities? Should they distribute 
profit to their owners or reinvest it in their social mission? Should they mobilize paid 
professionals prioritizing efficiency concerns or volunteers favouring a deep commitment to 
the mission? Hybrids need to find ways to deal with the multiple demands to which they are 
exposed.” 
However, besides their constant conflicts, studies suggest that hybrid companies, by incorporating 
environmental and social responsibilities in their value proposition, are able to capture superior 
workers for the same wage (or equivalent workers with a lower wage), state higher prices and enjoy 
higher levels of customer loyalty by matching the products and brands they sell with the ideas and 
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principles of their clients and employees (Markman et al., 2016). Furthermore, by being present in 
multiple fields, and combining different logics within a single organization, research also proposes 
that hybrid have a higher likelihood of innovating and leading to the creation of new practices and/ 
or institutions (Jay, 2013).   
As Jay (2013, p. 138) inquires: 
“What are the organizational consequences of participating in multiple fields, or of combining 
multiple logics under one organizational roof?” 
Considering the scenario exposed thus far, it is easy to understand that hybrid organizing give rise to 
both pros and cons. But in what does the combination of all the previous effects result in?  
One important aspect to study is the financially attractiveness of hybrid organizations. Questions, 
such as: Are hybrid organizations as financially attractive as for-profit businesses? How do they 
attract investment? typically arise in this context. Thus, in order to better understand the answers to 
such questions it is crucial to study the different features of “an investment approach that 
intentionally seeks to create both financial return and positive social or environmental impact that is 
actively measured” (World Economic Forum Investors Industries & Deloitte Touche Tohmatsu, 
2013, p.7) namely: Impact Investment 
2.2. Investment on Hybrid Organizations – Impact Investment 
A new type of investment is arising globally, one that targets, directly the creation of value (social, 
economic, cultural and/or environmental) in the society as well as financial return on investment. 
This endeavour is usually called “impact investment” (Ormiston et al., 2015).  
The term “impact investment” may be new, but the concept of combining investment and social 
objectives is not. The Commonwealth Development Corporation in the United Kingdom, founded in 
1948, stands as an example for how long this concept has been around since they are able to sustain 
their operations from earned income (O’Donohoe et al., 2010), although they “invest to support the 
building of businesses throughout Africa and South Asia, to create jobs and make a lasting difference 
to people’s lives in some of the world’s poorest place” (CDC Group, 2013). In recent years, however, 
the attempt to build an impact investing market has increased (Höchstädter & Scheck, 2015). 
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Impact investing was first introduced in 2007, by the Rockfeller Foundation, following an initiative 
that brought together numerous finance, philanthropy and development leaders. Conjointly, they 
debated the need for and means to build an industry that focused on investments with a positive social 
and environmental impact. Impact investment, just as traditional investment, involves capture funds 
in order to obtain financial returns. However, as hinted above, financial return is not its only purpose; 
impact investment also focuses on a social and/or environmental return, combining financial and 
philanthropic objectives (Höchstädter & Scheck, 2015). Actually this type of investment is 
differentiated from traditional financial investment due to its focus on a non-financial return yet, on 
the other hand, it also separates itself from grant funding and philanthropy precisely due to the 
financial return it aims to bring to investors (Höchstädter & Scheck, 2015).  
Impact investment can take many different forms, either by equity, debt or a mix of both with flexible 
demand levels of financial return – either at a market rate or below/above market. These varying 
levels of return reflect not only the individual risk seeking but also the motivations for each player to 
enter the market. Some organizations such as institutional investors, philanthropists, foundations and 
charities have already implemented some impact investment strategies – some of them are looking 
for financial returns whilst others deliberately accept reduced financial returns in order to pursue a 
greater social and/or environmental impact. In order to fully understand impact investment we must 
note that, by pursuing a blended vale creation between social impact and financial returns, we are 
challenging the long established dichotomy that proclaims an inverse relationship between these two 
factors (Ormiston et al., 2015). 
As previously stated, new impact investment funds have been emerging at an unprecedented rate. The 
market of impact investment is outstandingly fast and is creating a favourable environment for 
attracting investment, as Höchstädter & Scheck (2015, p. 450) note:  
“A number of mainstream financial players have been entering the field, launching funds (e.g., 
Deutsche Bank’s Impact Investment Fund I), engaging as investors (e.g., Goldman Sachs is 
invested in the Rikers Island Social Impact Bond), or researching the market (especial ly J.P. 
Morgan with its Social Finance Research division). An ecosystem has been developing, 
including investor networks such as the GIIN, reporting standards such as the Impact Reporting 
and Investment Standards (IRIS), rating agencies such as the Global Impact Investing Ratings 
System (GIIRS), and searchable online databases of investment products such as ImpactBase.” 
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Moreover, top-ranked universities, such as Columbia University, are introducing impact investment 
into the academic field by launching impact investment initiatives and including the topic in their 
syllabuses, as well as dedicating an increasing number of reports, articles, and so forth, to impact 
investment. The subject has also caught the attention of the public sector, having, for instance, the 
government of United Kingdom lead the way and others around the world followed the trend 
(Höchstädter & Scheck, 2015). 
Impact investment’s most important players have been individuals, foundations and family offices 
which, along with global development banks, have leaded impact investment, however, in current 
years, institutional investors are becoming increasingly attentive to the this market. The demand for 
impact investment occurs both in developed and developing countries, in projects regarding for-
profit, not-for-profit, and hybrid organizations, with varied social and environmental impacts. It is 
hard to have a precise notion of the size of the global market for impact investment, as information 
on transactions is not usually made publicly, and it is still hard to be fully sure of which projects and 
investments belong to the impact investment sector and which do not (Ormiston et al., 2015). The 
estimates vary greatly and it is not consensual what the present industry value is today, as we can see 
through Orminston et al. (2015, p. 355): 
“Estimates of the current market size vary significantly between commentators: (1) The Global 
Sustainable Investment Review (2013) reports US$89 billion in impact investment representing 0.14 
per cent of total managed assets of professionally managed funds actively applying ESG strategies. 
(2) J.P. Morgan and the GIIN’s (2013) third annual survey on the impact investment market reports 
that the 99 organizations that participated in the survey committed US$8 billion to impact investment 
in 2012, and plan to commit US$9 billion in 2013. Survey respondents reported cumulative 
allocations of US$36 billion since inception to impact investment. (3) The Impact Investor, which 
maps 380 different impact investment funds, reports that that total volume of capital managed by 
these funds in 2012 exceeds US$40 billion.” 
Other authors even suggest that impact investment is expected to reach one trillion dollars of invested 
capital by the year 2020 (Battilana & Lee, 2014). This growth of impact investing is in line what 
Dacin (2011, p. 1204) states:  
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“A broader movement gaining momentum in contemporary market economies, one demanding a 
more ethical and socially inclusive capitalism.” 
This movement is evidenced, for example, by the emergence and expansion of an increasingly ethical 
consumerism, and the growth of business ethics and corporate social responsibility movements. The 
parallel increased emergence of hybrid organizations helps proving the minimization of barriers 
between the social/environmental and economic/financial domains and also between for-profit and 
non-profit sectors. This contributes to the increased attention brought to the phenomenon by 
policymakers and academia (Höchstädter & Scheck, 2015). 
Over the past decade many different players have emerged all over the world – from new investors 
to focused funding intermediaries and policy makers in impact investment. The market changed and 
evolved from the “incoordination innovation” state to a structured market where various centres of 
activity and recent infrastructures contribute to increased activity and reduced transaction costs 
(Ormiston et al., 2015). 
Nowadays, impact investment represents a powerful opportunity for social entrepreneurs, since it 
focuses on providing the necessary funding for social innovation that addresses significant 
social/environmental problems. Such problems are usually complex, messy and interdependent and 
call for all-round solutions. Hence impact investment emerges as another means, besides traditional 
philanthropy and government funds, for these projects to effectively respond to such issues (Ormiston 
et al., 2015). As we have seen, impact investment is creating the financial structure for funding hybrid 
projects. Similarly for-profit entrepreneurs who have debt, equity, or a combination of both in order 
to fund their projects, hybrid organizations are now too faced with this reality in the wake of impact 
investment; they now have an option besides recurring to foundations´ and venture philanthropists 
funds, but how do hybrid organizations, specifically healthcare start-ups, are able to attract such 
investments? 
2.3. Investment on Healthcare Innovation 
Thinking about start-ups – defined broadly as newly registered firms, with at least one employee 
(often the founder) (Isenberg, 2016), or as a temporary organization designed to search for a 
repeatable and scalable business model (Blank, 2013) – is to think about innovation and disruption. 
In the healthcare industry, innovation is defined by Omachonu (2010, p.5) as: 
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“The introduction of a new concept, idea, service, process, or product aimed at improving 
treatment, diagnosis, education, outreach, prevention and research, and with the long term 
goals of improving quality, safety, outcomes, efficiency and costs.” 
This innovation has been responsible for huge increases in the world’s population wellbeing but, in 
times where the western societies healthcare systems are becoming increasingly costly (Davies & 
Boelman, 2016), and less developed countries public health challenges such as malaria, tuberculosis 
or HIV are still responsible for huge numbers of deaths and reduced living standards of the population 
(Friends of the Global Fight, 2017), there is still an enormous necessity and a strong case for 
investment in social innovations that respond to the challenges faced. 
However, although this necessity is well identified and of public interest, the government and public 
authorities have failed to become the innovators in this subject, being now clear that the disruptive 
innovation follows a bottom-up path, kicking off from specialized researchers or front-line health 
experts as the innovators (Chowdhury, 2012). Such players present, that way, an entrepreneurial 
mindset proving their ability to create new projects from new concepts, ideas and visions, and present 
themselves and their ventures as  the main responsible for the changes of the health care industry 
(Grazier & Metzler, 2006).  
Though, to finance innovation, it is key to focus on financing the new ventures and start-ups in the 
industry, and this way improving the quality of care, accessibility, and continuity of services offered 
to the population (Grazier & Metzler, 2006). 
Interestingly such ventures have chronically had on private investors, such as venture capitalists for 
example, an important financier. Even in times when the attractiveness, for  public entities, of 
healthcare ventures investments reduced, the private capitals kept entering maintaining their levels 
stable (Lee & Dibner, 2005). 
So, with one of the biggest challenge for start-ups being financing, that quest for investment easily 
becomes discouraging and ineffective (Grazier & Metzler, 2006). Considering the enormous 
relevance that investments has enabling the research and product development, which are on the basis 





The context in which the research was developed is the Portuguese healthcare ecosystem.  
Portugal is a country with a total population, in 2015, of approximately ten million people (INE, 
2017), where all residents have access to the national health care system (World Health Organization, 
2017). Regarding the health of its residents, Portugal is among the top 22 best countries in the world, 
positioning this way among the most developed countries globally (Lim et al., 2016).  
However, despite the good performance of the Portuguese population’s health, research and 
innovation on health is for Portugal a fundamental sector in an area where the country wants to 
become a major international player. Thus, innovation in health is constantly a topic of attention from 
public institutions, for example in 2014 it was specifically discussed in the Portuguese Parliament 
under the name of: “Think Tank – Inovar na saúde – Promover e Disponibilizar a Inovação aos 
Cidadãos” (Assembleia da República, 2014).  
Considered to be a strategic sector for the Portuguese economy, the industry covers, according to the 
most recent data, 1.114 firms and close to 11.000 workers, with exports in the sector have growing 
over 6,7% between 2011-2015 (AICEP, 2016). 
The quality of health care provided to citizens and the high level of research and science performed 
in universities and institutes makes it a reference sector in the country. However, the capitalization of 
this critical knowledge generated has not been done successfully so far, providing this way an 






4. Research Methodology 
Bearing in mind that we are dealing with recent topics (Battilana & Dorado, 2010; Battilana & Lee, 
2014; Battilana et al, 2015) that require further research, a qualitative methodology was adopted 
(Creswell, 2013) in order to understand what are the main factors that hybrid organizations, 
specifically in the health and social care industry, must address to attract investment. This exploratory 
study focuses on what are the main topics that must be understood according to the experience of 
individuals that are familiar with capital investments in hybrid organizations of the health sector.  
Qualitative research is defined by Corbin and Strauss (1990, p.17) such as: 
“By the term “qualitative research” we mean any type of research that produces finding not 
arrived at by statistical procedures or other means of quantification.” 
More specifically, the data collection technique chosen is a series of in-depth interviews with relevant 
players in hybrid organizations of the health and social care industry. The interviewees are specialists 
in the field – they are founders and/or managers of hybrid organizations, impact investors with past 
investment in the sector and accelerators specialized in the industry. 
Considering the dimension of this study, the in-depth interviews followed a semi-structured protocol, 
which is suitable for small-scale research studies (Boyce & Neale, 2006). The semi-structured 
technique consists in identifying the main aspects to be covered, by delineating the general layout of 
the interview, hence avoiding narrow focus on specific topics. This is an extremely flexible format 
which allows the interviewer to direct the interview towards his points of interest, yet allowing the 
interviewee freedom to express his thoughts. The detailed structure is, therefore, left to be worked 
out during the interview. This method, which is suitable for studies involving small samples, proved 
to be the most appropriate for this research, since 15 interviews were performed (Drever, 1995) 
4.1 Interview Protocols 
Three different interview protocols were created: one for founders and managers of hybrid 
organizations, another for investors and, lastly, a third one for consultants who deal directly with such 
organizations. These protocols were used as guiding lines but were adapted and improved as the 
interviewing process got along, in an ongoing and continuous process of feedback from previous 
interviews. As it would be expected, due to the singularities of each interviewee, the interviews differ 
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slightly from each other; however, the collection of information regarding the same topics was 
assured. The structure of the interview is explained in the tables of the appendix. The main points to 
be covered in the interview were the following: 
1. Identify the interviewee and the organization – foundation and history of the enterprise, 
position of the interviewee; 
2. Understand the project – core business, mission, beneficiaries and clients; 
3. Check details of past external investments – stage of the project, amount; understand the 
experience of the interviewee; 
4. Direct question on the personal opinion of the interviewee; 
5. Facts about the company and the interviewee. 
4.2 Interviews Performed  
The table below describes the interviews performed. The names of the organizations were replaced 




Table 4.2.1 Interviews Performed 
Code Country  Founding Year Number of workers Objective 
Projects 
A POR 2015 Thirteen (13) Solution for prosthetics adaption 
B POR 2015 Ten (10) 
Quick and convenient  medical care in 
all locations and at all times 
C POR 2015 Five (5) 
Tests that work as tools in the 
diagnosis of cancer 
D POR 2017 Three (3) 
Low-cost, user-friendly, portable 
tuberculosis diagnosis  device 
E POR 2016 Four (4) Antibacterial coating for catheters 
F SPA 2017 Four (4) 
Real-time monitoring of metastatic 
cancer progression based on a low 
invasive sampling 
G POR 2014 Three (3) 
Reconstructive surgery monitoring 
technology 
H POR 2016 Six (6) App for cancer prevention 
I POR 2017 Five (5) 
Complementary test for the diagnosis 
and prognosis of depression 
J POR 2012 Five (5) 
Biomaterial for preventive filling of 
bone infections 
K POR 2011 Five (5) 
Promote healthy eating habits and 
lifestyles, contributing to the fight 
against childhood obesity. 
Accelerators 
L IRL 2011 Seven (7) 
Shorten the time to market and to 
investment for MedTech companies 
M POR 2013 Five (5) 
Support companies to generate more 
jobs by taking advantage of the critical 
knowledge produced in the city 
Investors 
N POR 2015 Three (3) 
Invest and have an active part in the 
management of seed and early-stage 
projects in the area of Health Sciences 
O POR 2013 Thirty (30) 
Invest in pre-series A of highly 
innovative and disruptive technologies 
in therapeutics diagnostics, MedTech 
and digital health with operations in 
Portugal. 
The interviewees were divided in three different types of actors: projects – companies to whom the 
funds are destined –, investors – those who decide how and where to allocate the funds – and 
accelerators, defined by Radojevich-Kelley & Hoffman (2012, p. 57) as: 
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“Groups of experienced business people who provide services, office space, guidance, 
mentorship, networking, management services, knowledge, and expertise to nascent firms on 
an as-needed basis to help them succeed in the early stages of venture life.” 
Through the contribution of these three stakeholders, the aim is to have a further understanding of the 
investment process and environment, questioning the two parts that are directly involved – the 
investors and the companies to whom the investments are directed – about their experience, and also 
a third party – the accelerators – with a more equidistant point of view. 
Part of the interviews were performed at the offices of the companies. The organizations were 
contacted through cold e-mails or phone calls, which included a brief description of the aim of the 
research and the interest it had for the players in the industry. The contacts of the interviewees were 
obtained through a snowball sampling technique, in which each individual provides the researcher 
the contact of another one, who, in turn, contributes with a third, and so on (Atkinson & Flint, 2001). 
Considering the difficulty to obtain answers without being referred by someone of trust of the 
respondent, this “informal” method was considered to be ideal to reach the key players in the industry.  
As a result, the opportunity to attend the Worldwide Accelerator Rally at Oporto (WARP) arose, 
where part of the interviews were carried out. The event took place on the 11 th December 2017 and 
is described as follows (WARP, 2017):  
“WARP aims to ignite a cooperative movement between biomedical and health related 
innovation accelerators at international level, facilitating exchange of good practices and 
collaboration, and optimise the use of resources among accelerators. The program will focus 
on specific obstacles in innovation and entrepreneurship in the biomedical/health sector. 
The event will provide the opportunity to exhibit the technologies embedded in accelerators and 
to hold one-to-one meetings with potential investors and licensors.” 
At WARP, one-on-one meetings with investors, accelerators and CEOs or Executive Directors of 




5. Data analysis 
The data analysis followed a Grounded Theory methodology. This research method consists in 
repeatedly reading the data-corpus in order to obtain an overall view of the data collected in the in-
depth interviews, which in turn leads to the categorization of the information obtained for subsequent  
analysis (Coldwell, 2007). This coding approach to data is an active process of retrieving concepts 
and relevant information from a raw data-corpus (Rose et al, 2014). In this study, the categories 
distinguish and reflect on the different factors that influence investment in healthcare hybrid 
organizations as referred by the interviewees. Once those factors are identified, they are then given a 
conceptual label, called a code.  
One distinct strength of the grounded theory is its ability to investigate emerging topic areas or to 
shed new light on existing topics, performing effectively in uncertain contexts (Rose et al, 2014). Due 
to its inductive nature, promoted by carrying out the categorization process posteriorly to collecting 
the data, this is a method that will generate information that makes sense to subjects involved in the 
situation being researched and hence facilitates the approach to a practitioner audience (Glaser & 
Strauss, 2006). Considering this is an emerging topic, there is limited research and information on 
hybrid organizations and impact investment, which makes it difficult to categorize the data prior to 
its collection. Therefore, one can easily agree that the Grounded Theory methodology is effective in 
overcoming the lack of information and providing relevant and insightful contributions to the actors 





6.1 Healthcare Investment Environment 
Through research in the field, it was possible to understand that the healthcare industry is inserted in 
a very special investment market with its own particularities. As explained below by “L”, an 
international accelerator, this is a highly regulated industry with a strong demand for scientific 
evidence.  
The main difference is that you’re selling in a very regulated environment and the level of 
evidence and testing required is incredibly high. Before you launch a product in the market it 
has to go through a regulatory approval, in which you need to prove its safety and efficacy – 
those are two major costs. Showing safety and efficacy can take you ten years to do so, hence 
the shortest time to get a product in the market is 2-3 years, but, on the other hand, I can develop 
an app and put it on the market tomorrow. The timing is very different and not very friendly 
towards investment. (Interview – Accelerator L) 
The increased regulation and demand for scientific evidence lead to a slower paced environment, 
characteristic of the healthcare industry, which is referred by all the players in the different projects 
(namely the four interviewees who are not founders or managers of projects). “M”, besides 
highlighting the time factor, also mentions that large investments are required to kick-start a project 
in the healthcare industry as opposed to the amount required in other industries:  
The main difference of this industry is its pace. With very high bureaucratic levels and a legal 
and administrative component as a challenge, through intellectual property certifications, etc... 
I would add the financing challenge, which is much higher than our initial expectations. For 
example, one hundred thousand euros, which in the tech industry is enough to build an 
advanced product and a team, in this industry are not even close of what is needed to take-off. 
Therefore, the investment necessities are completely different and the investor profile is very 
different as well – usually they need to be people with a deep knowledge about the market and 
with an interesting network, going beyond the money. There are not many people like that 
profile in Portugal, and that is a huge challenge. Then we can highlight the entrance in the 
market, the certifications, the intellectual property, closing the deal, all of that is very slow. 
Then there is still a very particular detail on the market which is the fact that the product needs 
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to please all interested parts, the clinician, the patient, the hospital, etc… The value proposition 
has to be multi oriented and please more than one stakeholders. (Interview – Accelerator M) 
“M” also emphasizes the enormous influence that the different stakeholders have in the success of a 
given project, which “L” justifies as follows: 
You usually don’t sell to the user; you sell to the hospital, to the insurer or to the clinician 
commonly not to the user. (Interview – Accelerator L) 
In brief, the interviewees identify three main aspects that set the healthcare industry apart: the slow 
paced rhythm of the environment; the high level of investment required; and the large number of 
different stakeholders to please. Naturally, this leads to multiple obstacles that these projects and 
investors must face in order to succeed.  
6.2 Main Difficulties Encountered by Healthcare Hybrid Ventures 
So, what are the difficulties that the entrepreneurs face in such a particular market? “M”, a Portuguese 
experienced accelerator, gives a clear answer: 
I have been asking that to all start-ups I meet and the quick and straight answer, in Portugal 
and abroad, is always: financing. (Interview – Accelerator M) 
This view is coherent with the feedback provided by the other entrepreneurs interviewed. “A”, “H” 
and “J” mention, respectively: 
The biggest difficulty, which is applicable to any project of this kind, is investment. That is 
definitely the main one. (Interview –Entrepreneur A) 
The main problem is capturing investment. Without it we cannot move on. These projects are 
in the so-called death valley, because we need pre-clinical trials without them we cannot move 
forward, and we can only preform them with investment. (Interview – Entrepreneur H) 
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We received a scholarship to support entrepreneurs but we ended up spending the money in the 
company and could not develop a physical version even close to good enough. It happened 
because we did not have the access to the laboratory and the know-how to do it. (...) Capturing 
investment, precisely because of this, becomes of difficult access and so the main difficulty. We 
needed financing but since we offer a hardware project in the medical field it is very difficult 
to have what to show, have traction or sales which is the kind of metrics that an investor wants. 
(Interview – Entrepreneur J) 
It is clear that investment and funding is crucial in this industry due to the three aspects mentioned 
above that characterize the healthcare industry. “E” elaborates on this issue:  
As with all projects in the health area, we must pay close attention to the norms to be followed 
during the experiments and with the validation of the results obtained. It was also necessary to 
increase the number of people working on the project. For all of this and being able to scale 
the project requires considerable investment. (Interview – Entrepreneur E) 
Alongside with funding, the other main difficulty identified by all types of players is the transition 
process from a research project to a market driven one. This shift of focus, from the occurrences 
inside a lab to the market necessities and opportunities, demands different skills and increased funds 
and is hard to achieve it successfully. The Irish accelerator “L” and the Spanish entrepreneur “F”, 
respectively, agree that this transition is the main issue to be solved. 
By far the biggest problem is that companies develop technology first, when the necessity and 
the market are not clear. (Interview – Accelerator L) 
The most difficult thing is to know what is necessary to successfully move from a research 
project to an entrepreneurship one. Since it has absolutely nothing to do with each other. 
(Interview – Entrepreneur F) 
It is reasonable to assume that the difference in market maturity and available investors in the 
Portuguese market compared to international ones affect the kind of difficulties encountered by 
entrepreneurs; in other words, main difficulties may vary according to the geographical market in 
which the subject is inserted. This way as we have seen previously, Portuguese actors highlight the 
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funding process as the biggest challenge new ventures face, contrarily to the international players 
interviewed who point out the transition process as the main difficulty.  
Naturally, investors don’t identify lack of funding as their main difficulty. They too identify the 
transition from a lab to the market as their biggest obstacle, but from the point of view of someone 
who is familiar with the market and is apprehensive to collaborate with someone inexperienced. “N” 
and “O” state, respectively: 
The biggest difficulty we find is the focus of the teams, due to their structure, since most of the 
teams we work with are scientist and researchers not used to develop business projects outside 
of the academic world and that is a big obstacle for the project’s growth. (Interview – Investor 
N) 
On the CEO level there is a lot difficulties, most of the entrepreneurs that come here are pure 
scientists that have a good idea and, because of that, will become businessmen. That transition 
is not linear since the skill set is not the same at all. We are speaking of capturing capital for 
the company, for example, and that is not easy for pure researchers. You can be a brilliant 
scientist but to run a business you need different skills. (Interview – Investor O) 
Entrepreneur “I” draws a connection between lack of funding and lab-to-market transition:  
The biggest difficulty is finding the necessary funding for the transition between the research 
and the final product to be in market. (Interview - Entrepreneur I) 
Concluding the two main obstacles identified are funding the projects and the transition from the labs 
to the market. Admittedly, the investment in healthcare projects and how to attract it is a real worry 
and a huge obstacle that entrepreneurs face. It is essential to understand what the main factors that 
attract investment are. 
6.3 Factors that Attract Investment 
To understand what are the factors a project must gather in order to attract investment, according to 
entrepreneurs in the healthcare industry, we asked them directly. The answer given by “L” introduces 
plainly this topic: 
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What you are doing has to be absolutely ground breaking and the impact of your product has 
to be huge, whether on the patient, on the clinician – by saving them time or making their task 
easier–, or on the healthcare system – by cutting costs. If the clinician is not jumping over the 
table to grab your product from your hand, you probably won’t to be very successful. Still, you 
can do all that and not be funded. The problem you might face next is not having a big enough 
market to attract investment, which often happens. (…) I mean you can have a small market as 
long as the cost of getting it is also small (…) You must also look for clinical validation, meaning 
you must speak to circa 60 to 70 clinicians who tell you they would use your product. That 
clinical validation is very important. (Interview – Accelerator L) 
As explained by this accelerator, one must not only focus on a single factor. Instead, according to 
“L”, a product must offer a strong combination of: Innovation, Focus on the Market and Validation. 
Other interviewees further believe that an organization must gather three other factors in order to 
attract invest – a competent Team, high Social Impact and the potential of a strong Intellectual 
Property –, stating respectively: 
Innovation 
The fact that our project is a very innovative one, particularly when using an app - a tool still 
rarely used in this area – is, undoubtedly, what made us able to raise the necessary capital. 
(Interview – Entrepreneur H) 
As explained by entrepreneur “L”, a disruptive product – one so innovative that it could change 
people’s behaviour – is key for the success in this area. According to “O”, it is not possible to strive 
in this industry with only a different way to perform the same tasks. 
We only invest in projects where technology is definitely disruptive, projects that are copies of 
other ideas already seen in other parts of the world are not accepted (Interview – Investor O) 
In pursuance of disruption, “B” advises fellow entrepreneurs not to be constrained by standard 
behaviours and mind frames. 
Entrepreneurs must understand clearly the problem they are solving and do not focus on 
dogmas to find the best solution. (Interview – Entrepreneur B) 
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“B” also suggests that not only must you be disruptive but also thoroughly understand the problem 
that you are proposing to solve, implying an external focus, not only on the project itself, but on its 
necessity in the market. “G” explains the reason behind his product’s success and says that a 
disruptive technology as well as the continuous assessment of the market and his competitors was 
essential.  
Regarding reconstructive plastic surgery (in congenital diseases, burns, cancer) multiple 
surgeries are often required to improve the patient’s life. Currently there are other systems 
available that automatically quantify facial movements, but the G system has important 
advantages: the cost of the required hardware is low; is a portable system; no specific 
installation settings are required; works in 3D. The system is ahead of its competitors. 
(Interview – Entrepreneur G) 
“G” illustrates perfectly the situation exposed: to begin with, he pinpointed a necessity in the market, 
and then he used disruptive technology to tackle the issue. As a consequence, he built an attractive 
project with an advantage over his competitors. 
Market Drive 
As mentioned previously, market research cannot be ignored, even though different entrepreneurs put 
different focuses on distinct aspects of the market. For instance, “E” focuses on market size and argues 
that a product must have potential to scale in order to fulfill the demands of a large market. 
It is essential to have an idea that can easily be escalated. (Interview – Entrepreneur E) 
Just like “E”, “I” also highlights the size of the market along with other factors such as the demand 
of the market and limited number of competitors. 
Our product will have a very huge impact in a market that covers a large number of patients. 
The market is large and the number of competitors is low. (Interview – Entrepreneur I) 
A more complex approach is proposed by both “F” and “A”, who introduce the concept of product-
market fit. “A” also warns about the fact that, in this industry, the users are often not the buyers; this 
means that, in case the user and the buyer are not the same, both of them must always be taken into 
consideration.   
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Finding out if there is a product-market fit (...) it's very important to focus on the customers. 
Talk to many people, many customers, and realize who has influence on the purchase decision, 
(...) so not only the users, not only the buyers, but all of those who have a say about the product, 
it must be built a value proposition for all involved. (Interview – Entrepreneur A) 
On the other hand, “N”, as a trained investor, argues that the size of the market is not relevant. Niche 
projects are also interesting to invest in – as long as the demand is clear, a niche market in the 
healthcare industry may represent millions of users. “L” also explored this idea:  
For the project to become attractive it is essential that the entrepreneur is able to clearly 
identify the need, not necessarily the size of the market because a niche on a global scale can 
be a market of millions of users. (Interview – Investor N) 
The problem you might face next is not having a big enough market to attract investment, which 
often happens. This does not necessarily mean the absolute size of the market, but the ratio 
between market opportunity vs. the cost of entering that market. I mean you can have a small 
market as long as the cost of getting it is also small. (I-L) 
It is important to understand how the product fits within the market; in that sense, it might be 
advantageous to have a well-delineated business case, referred by “H”, and exit strategy, as pointed 
out by “L”. Entrepreneurs and accelerators often ignore this, however, an obvious and properly 
structured exit will more likely attract investment. 
One way you can differentiate yourself is building a roadmap clear about the next steps. 
(Interview – Entrepreneur H) 
An investor looks for projects that are attractive acquisition targets; this is, not only to him/her 
but also to other investors. Illustrating this with an example: an investor who injects 9 million 
euros in a company might be looking for a return of 10 times that amount, i.e. 90 million euros, 
which he might get if someone else acquires the company. So if they find a company whose 
acquisition is very attractive – for example, the J&J portfolio –, that’s a big plus, even though 
entrepreneurs usually fail to think this way. An investor is always thinking about their exit, how 




Besides the importance of focusing on the market status, “L” stresses that investors value a team with 
past experience in management, who can promptly react to market changes:  
Investors normally prefer a team with experience in running a business, however this is not 
something that we, accelerators, would usually look for and that is an additional risk we face. 
(Interview – Accelerator L) 
“M” goes a step further by stating: 
It is a combination of technology, approach to the market, and have a team capable of offering 
both. (Interview – Entrepreneur M)  
In just one sentence, “M” summarizes the three points analyzed thus far: innovation, market and team. 
According to his experience, these three factors are intertwined and gather the main characteristics 
that an investor looks for in a project. It is important to take notice, however, that only “L”, as an 
investor, refers concretely to the characteristic he values the most in a team – past experience in 
business; the entrepreneurs and accelerators refer to the team subjectively, valuing the general welfare 
of their relationships. Entrepreneur “B” argues that, in the early stages, given that the business model 
is well thought out, the most important factor for investment decisions is the quality of the team.  
The belief in a business model that made sense (although with adaptations that we have come 
to materialize) and verified that necessary condition, the critical factor was the team’s 
evaluation that was considered to be very strong by the investors. In such an early phase of the 
company's life, the most critical factor of success is the team’s quality (Interview – 
Entrepreneur B) 
A strong team that builds a positive impression on the investor is critical for the company’s success. 
In fact, the importance of a well-rounded team is also highlighted by “A”, who emphasizes the value 
brought by the diversity of its members: 
The investors really liked the team and saw that, XXX (the other founder) and I, are very 




Validation within the healthcare industry reassures investors about the feasibility of the product. “A”, 
who believes that the validation of their product by different parties enhanced its attractiveness for 
investment,  and “F”, who was able to present patients and clinicians using the product through many 
years, state respectively: 
We had validation at the university-level, at COITECH and at Carnegie Mellon in the US, we 
also had a good international advisory board and letters from clients saying that if it were to 
market they would buy. (Interview – Entrepreneur A) 
The fact we already had a prototype and also already proven our work with doctors on clinics. 
When we tried to capture investors we already had many years with clinicians using our 
product in patients. (Interview – Entrepreneur F) 
As mentioned previously by “M”, many different stakeholders interact in the healthcare industry and 
all must be pleased. “G” supports this idea by stressing the importance of obtaining validation from 
all stakeholders:  
If it is a medical technology to be used in medical field, it is very important to always have the 
opinion (and, if possible, participation) of clinicians. (Interview – Entrepreneur G) 
Intellectual Property 
Intellectual property rights are valuable assets for companies that protect their business, so they are 
key to any valuable product placed in the market. However, it must be created properly in order to 
become an advantage instead of a leverage.  
The potential of patent creation and the fact that we have not done it yet, because the CEO of 
X (our investor) is a specialist in this area, with several patents already created, and he liked 
having a technology that could be patented and that he could work on it with us. (Interview – 
Entrepreneur A) 
Instead of rushing into the application process just for the sake of holding a patent, “A” firstly sought 
for investment. In fact, their investor saw value in their intellectual property and was satisfied by the 
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opportunity to work conjointly with the company in obtaining a patent. This opinion is shared by the 
two investors interviewed, “N” and “O”, who explain why they like to get involved:  
Little preparation on intellectual property often kills the project from the beginning. Especially 
at the level of patents, because often these are poorly made and when it is the case we do not 
invest. (Interview – Investor N) 
About patents: they do not need to have patents created, provided they have not disclosed 
anything, we can, with our knowledge, create it. Here in Portugal all patent specialists are 
lawyers and not people who have knowledge in this area. This leads to a problem because the 
projects arrive with very fragile patent. You never know how strong the patent is until the time 
when the company starts to grow, only then the patent strength is tested and, if poor, it is already 
too late. We have worked with a specialized international office, the best in the world, to make 
patents to the projects we support and when it is not done by them the first thing we do is to ask 
them to review the patents already made here in Portugal to realize their strength. (Interview 
– Investor O) 
“N” considers it to be the most determinant factor when deciding to invest. If the patent is not 
correctly made and actually protecting the intellectual property, the project is not worth of investment. 
“O” also offers a solution to companies that they support using their network to provide a strong and 
reliable patent. 
Social Impact 
In light of organizational hybridity, “M” affirms that a positive social impact is crucial for projects to 
reach their financial objectives. 
In this industry, my perception tells me that when someone proposes to bring a solution to a 
pressing problem - for example, trying to diagnose cancer early - that factor continues to have 
a very significant effect. The ambitious and inspiring character makes investors also want to 
be part of the project. (Interview – Accelerator M) 
“M” argues that, particularly in the healthcare industry, some degree of romanticism still prevails and 
that investors still consider the impact of their actions in society. This idea is shared and confirmed 
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by “H” and “E”, who also believe that the fact that their projects have a direct and substantial positive 
impact on society greatly influenced investors when it came to embracing their projects over others:  
From the social impact point of view it is not necessary to explain the advantages of having 
such an application – which helps to prevent cancer – since it is immediate. So, while attracting 
investment, having a direct social impact turned out to be a big advantage. (Interview – 
Entrepreneur H) 
This project addresses a global huge hospital-wide problem, with serious consequences for 
patients and very high costs for hospitals. (...) The greater the impact of our project in society 
in general, the easier it is to raise funds. (Interview – Entrepreneur E) 
Coherent with the definition of impact investment we can see that having a great and direct social 
impact attracts investors to such projects.  
In conclusion, figure 6.3.1 illustrates the six main factors that the fifteen actors in the market 
highlighted as the most important ones to attract investment for a given project. 




















The objective of this dissertation is to study what are the main factors that a hybrid organization in 
the healthcare industry should gather in order to offer profitable opportunities for investment.  
Hybrid, in general, refers to the condition of being built through the combination of two or more parts 
of different elements (Battilana & Lee, 2014). When dealing with organizations, hybridization refers 
to combining parts of different institutions that in the past were considered to be restricted to one 
specific sector or organizational form (Markman et al., 2016).  
In this study, the organizations met the selection criteria in regards to their hybridity if they presented 
themselves as a for-profit business with the incorporation of social responsibility in their values 
and/or combined market and academic rationales, with the intention of advancing the medical 
discovery in biotechnology firms. Most of the organizations – all of whom integrate economic-
financial with social or academic logics, hence fulfilling the definition of hybrid organizations – 
presented themselves as healthcare start-ups. The healthcare industry is very particular in the fact that 
it is so intricately associated with social responsibility, as imposed by bioethics entities, such as the 
International Bioethics Committees (UNESCO, 2010). Therefore, one can easily understand that in 
the healthcare industry, in light of this particularity, the definition of “start-up” and “hybrid 
organization” may be overlapped, when taking in consideration that healthcare start-ups tend to solve 
social problems whilst seeking financial return. 
Bearing in mind that we are dealing with recent topics (Battilana & Dorado, 2010; Battilana & Lee, 
2014; Battilana et al., 2015) that require further research, a qualitative methodology was adopted, 
performing an exploratory study focusing on the experience of individuals that are familiar with 
financing operations of healthcare start-ups. This was accomplished through a series of in-depth 
interviews with relevant players in the healthcare industry – founders and/or managers of healthcare 
start-ups, investors and accelerators specialized in the sector. 
The data analysis followed a Grounded Theory methodology: the data-corpus was repeatedly read 
and, as a result, an overall view of the data collected during the in-depth interviews was obtained, 
which in turn lead to the categorization of the information for subsequent analysis (Coldwell, 2007).  
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Through the contribution of these three types of stakeholders, it was possible to retrieve the distinct 
aspects that characterize this industry and the main obstacles that healthcare start-ups must overcome 
when trying to prosper.  
Since the healthcare industry is an extremely regulated environment, with a high level of evidence 
required prior to launching a product in the market, its environment moves at a very slow pace and it 
may take years before an entrepreneur can actually sell his product to the public. Another key factor 
that characterizes this industry is the high level of investment required for each project. This adds up 
to the main difficulty encountered by healthcare entrepreneurs in the Portuguese market: the access 
to funding. In fact, understanding the reasons behind this difficulty and seeking the necessary tools 
to overcome this obstacle were the greatest motivations of this study. Besides the difficulty in 
accessing to investment, other players in the market, especially international ones, highlight the 
struggle in transitioning from the lab, where the product is developed, to the market. 
To tackle the obstacles detected, six factors were identified as key in improving attractiveness for 
investment in this market. 
Firstly, innovation was closely associated to product/service success. In such a competitive market, a 
company must develop disruptive ideas in order to strive; otherwise, it will fail to standout from other 
existing products. 
Even though a company must commit to innovation, the necessity of the market must always be taken 
into account. Therefore, the second factor identified was the focus on the market. Some interviewees 
highlight the size of the market as the most important aspect; however, this was not a unanimous  
belief. Still, all interviewees could agree on the fact that it is crucial to have a clear and well -defined 
market. Some also argued that, given the plurality of stakeholders involved in the healthcare industry, 
a company must consider all stakeholders’ needs and meet as many different interests as possible. In 
fact, the user is not usually the buyer and the decision to buy the product depends on a broad number 
of different types of actors in the industry.  
Thirdly, investors also show great interest in the profile of the founders’ team, valuing specially teams 
with past experience in the business world. 
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Fourthly, validation assures investors that third parties, such as clinicians, also saw interest in the 
product. This is particularly handy when dealing with start-ups, which usually don’t have concrete 
results they can present at an initial phase. Validation also provides credibility and safety demanded 
by the investors.  
Fifthly, the two investors expressed the value attributed to intellectual property. A poor patent, that 
fails to protect the idea properly hence reduces greatly its financial attractiveness, is a good enough 
reason for an investor not to invest. Investors even often like to get involved in the application process 
for a patent, to assure a strong patent is obtained. 
Lastly, a positive social impact is referred to as an important characteristic that an investor looks for, 
affecting the likelihood of a project obtaining its necessary funding. In other words, an ambitious and 
impactful project allures investors to get involved. 
All in all, one must not focus on one factor only; in fact, excelling at just one of them may be 
insufficient to capture investment. Entrepreneurs must deliver a compelling combination of these six 
factors in order maximize their chances of attracting the necessary capital to scale and reach new 
markets, and to offer improved and cheaper products and treatments, creating a positive impact on, 





This exploratory study aims to contribute with information about a growing industry that still remains 
understudied, particularly in Portugal. By focusing on the healthcare industry, the results are context 
dependent; however, more specific information is valuable for the players involved, may it be from a 
financial point of view or even from the users’ and general population’s perspective. Either way, 
health will always be a pressing matter and, consequently, investment in health will continuously 
yield one of the highest rates of return that a country can achieve. In this study, using a Grounded 
Theory approach to draw information from the direct testimonials of the players facilitates the 
translation of the information to the market, to some extent.  
The combination of different opinions from different types of stakeholders – 11 entrepreneurs, 2 
accelerators and 2 investors – is useful to formulate a wider theory that aligns expectations and helps 
to stimulate the growth of an emerging market in Portugal. 
Being the access to funding one of the main obstacles found by players in the Portuguese market this 
dissertation can help by exploring the reasons behind this difficulty and providing information for 
companies to gather the necessary tools to overcome this obstacle and successfully gather investment. 
7.2 Limitations 
One limitation of this study is the fact that it is practically based on the Portuguese market solely – 
only two out of the fifteen interviewees were not Portuguese – which, obviously, limits the 
reproducibility of the results in other geographical markets. Secondly, the sampling number of 
interviews is relatively small due to the fact that the market in Portugal is still very immature, with 
few players and of difficult access. Furthermore, most of the contact attempts were ignored. Also, 
given this is an understudied subject, bibliographical support is very limited, especially in Portugal 
where information is almost inexistent. Lastly, this dissertation only presents a snapshot of the 
industry, in the sense that it describes the situation at a given moment, as opposed to a longitudinal 
view, which would monitor the progression of the industry.  
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7.3 Future Research 
Further research is required to study the level of importance of each factor over others and the 
interconnection between them; to evaluate the situation at an international level, with actors from 
different markets, in order to understand the differences between geographical areas; to determine 
whether certain characteristics of a market influence the relative importance of each factor; and, l astly, 






8. Appendix  
Table 3.1 Interview Founder or Manager of a Hybrid Organization in the Health Sector  
Dimension Objective Questions 
Know the 
company 
Identify the interviewee and 
the company – foundation 
and history of the enterprise, 
position of the interviewee 
1. Thank you _________ for accepting the 
invitation for the interview. As an introduction, can 
you please tell me about the creation of _____? And 
what is your current role on the company? 
Understand the project – 
core business; mission; 
beneficiaries; and clients – 
and its foundation 
2. Can you tell me a little bit about the mission and 
the business of ______________? 
3. About the story of ___________? How did the 
idea came, and what it took to make it a reality? 
4. Between the foundation of __________ and 
today, which are the main difficulties you found 
along the way to keep the project growing? 
Past 
investments 
Check details of past 
external investments – stage 
of the project, amount, 
investors 
5. Financially speaking, how was the project funded? 
Meaning what was the proportion of external 
investment occurred, and by whom? 
6. Did __________ already had any external 
investment? What can you tell us about that 
experience? (want to know who invested, at what 
stage of the company) 
7. What did, in your opinion, mostly influenced the 
investors to choose your project? 
Future 
investments 
Direct question about the 
personal opinion of the 
interviewee 
9. What recommendations do you have, for future 
entrepreneurs create attractive projects for investors?  
Relevant 
Data 
Facts about company and 
interviewee 
10. Now some facts about ___________ – year of 
foundation; number of workers; Number of external 
investors (in terms of capital) and who? 
11. About yourself, can you tell me your: Age, 





Table 3.2 Interview Consultant of Hybrid Organization in the Health Sector 
Dimension Objective Questions 
Know the 
company 
Identify the interviewee and 
the company  – foundation 
and history, position of the 
interviewee 
1. Thank you ________ for accepting the invitation 
for the interview! As an introduction, can you 
please tell me about the creation of ________? And 
what is your current role on the company? 
Understand the project 
mission, and interest for the 
health sector 
2. Can you tell me a little bit about the mission and 
the business of _____________? 
3. Why focus on the healthcare industry? What’s 
special on the industry so that you focus only in 
companies in the health-care sector? What 
distinguishes the sector from the others? 
Company 
activity 
Understand the experience 
of the interviewed. Check 
details of past experiences 
in the field 
4. Considering that you support projects to attract 
investment what do you consider to be the main 
difficulties companies find that activity? 
6. Which are the most important factors of a project 
that you look for when helping it to find investors? 
7. Which are, in your opinion, the most important 
factors investors look for when deciding to invest, or 
not, in a project? 
Direct question about the 
personal opinion of the 
interviewee 
8. What recommendations do you have, for future 
entrepreneurs in the industry to create attractive 
projects for investors? 
Relevant 
Data 
Facts about company and 
interviewee 
10. Now some facts about _______ – year of 
foundation; number of workers; Number of 
companies supported 
11. About yourself, can you tell me your: Age, 






Table 3.3 Interview Investor in Hybrid Organization in the Health Sector  
Dimension Objective Questions 
Know the 
company 
Identify the interviewee and 
the company  – foundation 
and history, position of the 
interviewee 
1. Thank you ________ for accepting the invitation 
for the interview! As an introduction, can you 
please tell me about the creation of ________? And 
what is your current role on the company? 
Understand the project 
mission, and interest for the 
health sector 
2. Can you tell me a little bit about the mission and 
the business of _____________? 
Company 
activity 
Understand the experience 
of the interviewed. Check 
details of past experiences 
in the field 
3. Considering that you focus on projects on the seed 
and growth stage what do you consider to be the 
main difficulties companies find between those 
stages and the maturity? 
4. Which are, in your opinion, the most important 
factors when deciding to invest, or not, in a project? 
Direct question about the 
personal opinion of the 
interviewee 
5. What recommendations do you have, for future 
entrepreneurs create attractive projects for investors?  
Relevant 
Data 
Facts about company and 
interviewee 
6. Now some facts about _______ – year of 
foundation; number of workers; Number of 
companies supported 
7. About yourself, can you tell me your: Age, 
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